CD8A and neoplasm: We previously demonstrated that the OC tumor endothelium acted as a potent immune barrier by expressing the death mediator Fas ligand (FasL/CD95L) that preferentially killed CD8+ T cells, and such FasL expression was cooperatively induced by tumor-derived VEGF, IL-10, and PGE219.